Session Information
2009 BIO International Convention
Click here to go to the previous page
Clinical Trials for Novel Therapeutics: Challenges and Opportunities of Uncharted Waters
Track : Clinical Research/Clinical Trials
Program Code: 2718
Date: Thursday, May 21, 2009
Time: 10:00 AM to 11:30 AM  EST
Location: B405
SPEAKER (S):
Tim Cote, U.S. Food and Drug Administration
Patricia Furlong, Parent Project Muscular Dystrophy
Robert Glassman, MD, Private Equity Partner, Orbimed Advisors, LLC
Ed Kaye, MD, Genzyme Corporation
Langdon Miller, MD, PTC Therapeutics, Inc
Description
As technology becomes grows increasingly sophisticated, scientists are able to expand their targets to diseases and disorders that were formerly untreatable. With the opportunity to develop treatments for diseases with unmet medical needs comes the challenges of designing clinical trials. This panel of researchers, clinicians and members of the advocacy community will describe their experiences designing clinical trials in an area with no historical experience, share lessons learned and their recommendations for moving forward.

• Describe design and implementation of clinical trials for diseases with unmet medical need
• Increase understanding of challenges inherent in designing "first in category" treatments
• Gain knowledge about best practices and recommendations for future activities


Audio Synchronized to PowerPoint
(Code: 2718)
  
This session is a part of: